Nivolumab/vemurafenibVarious toxicities: 4 case reports

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2018年 / 1706卷 / 1期

关键词：

D O I：

10.1007/s40278-018-47708-7

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：379 / 379

相关论文

共 50 条

[21] Atezolizumab/nivolumab/pembrolizumabVarious toxicities: 4 case reports
Reactions Weekly, 2018, 1707 (1) : 56 - 56
[22] Ipilimumab/nivolumab/pembrolizumabVarious toxicities: 4 case reports
Reactions Weekly, 2018, 1705 (1) : 176 - 176
[23] Nivolumab/zoledronic acidVarious toxicities: 4 case reports
Reactions Weekly, 2022, 1900 (1) : 258 - 258
[24] Ipilimumab/nivolumab/pembrolizumabVarious toxicities: 4 case reports
Reactions Weekly, 2020, 1792 (1) : 136 - 136
[25] Ipilimumab/nivolumab/pembrolizumabVarious toxicities : 4 case reports
Reactions Weekly, 2021, 1886 (1) : 239 - 239
[26] Ipilimumab/nivolumab/pembrolizumabVarious toxicities: 4 case reports
Reactions Weekly, 2021, 1857 (1) : 183 - 183
[27] Ipilimumab/nivolumab/pembrolizumabVarious toxicities: 4 case reports
Reactions Weekly, 2018, 1685 (1) : 117 - 117
[28] VemurafenibVarious toxicities: case report
Reactions Weekly, 2016, 1612 (1) : 200 - 200
[29] Dabrafenib/interferon-α/vemurafenibVarious toxicities: 2 case reports
Reactions Weekly, 2021, 1870 (1) : 111 - 111
[30] VemurafenibVarious toxicities: case report
Reactions Weekly, 2016, 1590 (1) : 187 - 187

← 1 2 3 4 5 →